COF vs STRO
Capital One Financial Corporation (COF) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the COF and STRO stock pages for the full models.
Not investment advice.